{"id":200048,"date":"2026-08-12T16:07:14","date_gmt":"2026-08-12T10:37:14","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=200048"},"modified":"2026-08-12T16:07:17","modified_gmt":"2026-08-12T10:37:17","slug":"nifty-pharma-today-12-august-2026-16-00","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/nifty-pharma-today-12-august-2026-16-00\/","title":{"rendered":"Nifty Pharma Today: Index Performance, Stocks, Gainers"},"content":{"rendered":"

Nifty Pharma<\/a> today closed with a marginal gain, reflecting a session where broad participation stayed positive even though the headline move was small. The index stood at 26,762.5, up 12.05 points or 0.05% from the previous close of 26,750.45. That makes this a mildly positive day rather than a strong trending one, but the internal picture was healthier than the headline suggests because a clear majority of stocks in the index ended in the green.<\/p>\n

For users tracking Nifty Pharma live, Nifty Pharma performance, and Nifty Pharma stocks today, the most important takeaway is that the sector held steady after opening near flat, slipping to an intraday low of 26,601.7, and then recovering toward the upper end of the day\u2019s range. The index opened at 26,763.85, almost unchanged from the prior close, and later touched a day high of 26,797.9. That intraday structure points to resilience in buying interest after the early dip.<\/p>\n

Within the constituent basket, advances were led by Zydus Lifesciences Ltd.<\/a>, Ipca Laboratories Ltd.<\/a>, and Ajanta Pharma Ltd.<\/a>. On the downside, JB Chemicals & Pharmaceuticals Ltd.<\/a> was the clear laggard, followed by Gland Pharma Ltd.<\/a> and Alkem Laboratories Ltd.<\/a>. Large and active names such as Sun Pharmaceutical Industries Ltd.<\/a>, Divi’s Laboratories Ltd.<\/a>, Cipla Ltd.<\/a>, and Dr. Reddy’s Laboratories Ltd.<\/a> were relatively stable, which also helps explain why the overall index move remained contained.<\/p>\n

This article gives a full, data-led view of Nifty Pharma today using verified index price action, market breadth, top gainers, top losers, heavyweight performance, and the complete available stock list. Where deeper metrics such as valuation multiples, fund flows, or indicator readings are not included here, the interpretation focuses on what today\u2019s actual price and breadth data clearly show.<\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n